期刊
MOLECULES
卷 27, 期 14, 页码 -出版社
MDPI
DOI: 10.3390/molecules27144446
关键词
sensitivity; antimicrobial resistance; selection; screening; chemical genetics; bioinformatics; drug discovery; tuberculosis
资金
- Canadian Institutes for Health Research (CIHR project) [PJT148646]
- British Columbia Lung association
- Tres Cantos Open Lab foundation
Through chemical-genetic characterization and whole genome sequencing analysis, novel drug targets and drug resistance genes associated with Mycobacterium tuberculosis (Mtb) intracellular growth were identified. The exploration of Mtb chemical mutant genomes could aid in novel drug discovery and the understanding of tuberculosis treatment mechanisms.
Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis, is one of the most devastating infectious agents in the world. Chemical-genetic characterization through in vitro evolution combined with whole genome sequencing analysis was used identify novel drug targets and drug resistance genes in Mtb associated with its intracellular growth in human macrophages. We performed a genome analysis of 53 Mtb mutants resistant to 15 different hit compounds. We found nonsynonymous mutations/indels in 30 genes that may be associated with drug resistance acquisitions. Beyond confirming previously identified drug resistance mechanisms such as rpoB and lead targets reported in novel anti-tuberculosis drug screenings such as mmpL3, ethA, and mbtA, we have discovered several unrecognized candidate drug targets including prrB. The exploration of the Mtb chemical mutant genomes could help novel drug discovery and the structural biology of compounds and associated mechanisms of action relevant to tuberculosis treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据